XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Total
Ordinary Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Noncontrolling Interests
Balance at the beginning of period at Dec. 31, 2018 $ 1,753,647 $ 1,739,202 $ 77 $ 2,744,814 $ 1,526 $ (1,007,215) $ 14,445
Balance at the beginning of period (in shares) at Dec. 31, 2018     776,263,184        
Increase (Decrease) in Stockholders' Equity              
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     916,383        
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 6,269 6,269 $ 1 6,268      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     2,066,383        
Share-based compensation 26,392 26,392   26,392      
Other comprehensive income (loss) 4,440 4,546     4,546   (106)
Net loss (168,069) (167,640)       (167,640) (429)
Balance at the ending of period (in shares) at Mar. 31, 2019     777,413,184        
Balance at the end of period at Mar. 31, 2019 1,622,679 1,608,769 $ 78 2,777,474 6,072 (1,174,855) 13,910
Balance at the beginning of period at Dec. 31, 2018 1,753,647 1,739,202 $ 77 2,744,814 1,526 (1,007,215) 14,445
Balance at the beginning of period (in shares) at Dec. 31, 2018     776,263,184        
Increase (Decrease) in Stockholders' Equity              
Net loss (562,683)            
Balance at the ending of period (in shares) at Sep. 30, 2019     784,440,698        
Balance at the end of period at Sep. 30, 2019 1,294,237 1,278,478 $ 78 2,861,012 (14,830) (1,567,782) 15,759
Balance at the beginning of period at Mar. 31, 2019 1,622,679 1,608,769 $ 78 2,777,474 6,072 (1,174,855) 13,910
Balance at the beginning of period (in shares) at Mar. 31, 2019     777,413,184        
Increase (Decrease) in Stockholders' Equity              
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     3,223,701        
Contributions from shareholders 4,000           4,000
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 4,373 4,373   4,373      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     3,802,747        
Share-based compensation 32,602 32,602   32,602      
Other comprehensive income (loss) (6,436) (6,297)     (6,297)   (139)
Net loss (85,954) (85,570)       (85,570) (384)
Balance at the ending of period (in shares) at Jun. 30, 2019     784,439,632        
Balance at the end of period at Jun. 30, 2019 1,571,264 1,553,877 $ 78 2,814,449 (225) (1,260,425) 17,387
Increase (Decrease) in Stockholders' Equity              
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     (4,170,283)        
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 9,745 9,745   9,745      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     4,171,349        
Share-based compensation 36,818 36,818   36,818      
Other comprehensive income (loss) (14,930) (14,605)     (14,605)   (325)
Net loss (308,660) (307,357)       (307,357) (1,303)
Balance at the ending of period (in shares) at Sep. 30, 2019     784,440,698        
Balance at the end of period at Sep. 30, 2019 1,294,237 1,278,478 $ 78 2,861,012 (14,830) (1,567,782) 15,759
Balance at the beginning of period at Dec. 31, 2019 $ 978,355 962,205 $ 79 2,925,970 (8,001) (1,955,843) 16,150
Balance at the beginning of period (in shares) at Dec. 31, 2019 801,340,698   801,340,698        
Increase (Decrease) in Stockholders' Equity              
Issuance of ordinary shares in connection with collaboration $ 2,162,407 2,162,407 $ 21 2,162,386      
Issuance of ordinary shares in connection with collaboration (in shares)     206,635,013        
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     3,705,468        
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 11,629 11,629 $ 1 11,628      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     3,706,573        
Share-based compensation 38,255 38,255   38,255      
Other comprehensive income (loss) 1,349 1,453     1,453   (104)
Net loss (364,939) (363,735)       (363,735) (1,204)
Balance at the ending of period (in shares) at Mar. 31, 2020     1,007,976,816        
Balance at the end of period at Mar. 31, 2020 2,827,056 2,812,214 $ 101 5,138,239 (6,548) (2,319,578) 14,842
Balance at the beginning of period at Dec. 31, 2019 $ 978,355 962,205 $ 79 2,925,970 (8,001) (1,955,843) 16,150
Balance at the beginning of period (in shares) at Dec. 31, 2019 801,340,698   801,340,698        
Increase (Decrease) in Stockholders' Equity              
Other comprehensive income (loss)         7,582    
Net loss $ (1,127,874)            
Balance at the ending of period (in shares) at Sep. 30, 2020 1,182,916,659   1,182,916,659        
Balance at the end of period at Sep. 30, 2020 $ 4,296,514 4,287,494 $ 118 7,367,799 (419) (3,080,004) 9,020
Balance at the beginning of period at Mar. 31, 2020 2,827,056 2,812,214 $ 101 5,138,239 (6,548) (2,319,578) 14,842
Balance at the beginning of period (in shares) at Mar. 31, 2020     1,007,976,816        
Increase (Decrease) in Stockholders' Equity              
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     3,493,516        
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 16,569 16,569 $ 1 16,568      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     10,493,392        
Share-based compensation 45,468 45,468   45,468      
Deconsolidation of a subsidiary (3,545)           (3,545)
Other comprehensive income (loss) (2,738) (2,751)     (2,751)   13
Net loss (336,318) (335,202)       (335,202) (1,116)
Balance at the ending of period (in shares) at Jun. 30, 2020     1,014,976,692        
Balance at the end of period at Jun. 30, 2020 2,546,492 2,536,298 $ 102 5,200,275 (9,299) (2,654,780) 10,194
Increase (Decrease) in Stockholders' Equity              
Issuance of ordinary shares in connection with collaboration 2,069,610 2,069,610 $ 14 2,069,596      
Issuance of ordinary shares in connection with collaboration (in shares)     145,838,979        
Issuance of shares reserved for share option exercises 1 1 $ 1        
Issuance (use) of shares reserved for share option exercises and RSU releases (in shares)     5,525,182        
Exercise of options, ESPP and release of Restricted Share Units (RSUs) 47,632 47,632 $ 1 47,631      
Exercise of options, ESPP and release of Restricted Share Units (RSUs) (in shares)     16,575,806        
Share-based compensation 50,297 50,297   50,297      
Other comprehensive income (loss) 9,099 8,880     8,880   219
Net loss $ (426,617) (425,224)       (425,224) (1,393)
Balance at the ending of period (in shares) at Sep. 30, 2020 1,182,916,659   1,182,916,659        
Balance at the end of period at Sep. 30, 2020 $ 4,296,514 $ 4,287,494 $ 118 $ 7,367,799 $ (419) $ (3,080,004) $ 9,020